Journavx (suzetrigine) by Vertex Pharmaceuticals represents a major advancement in pain management, offering a non-opioi...
Pandemics: Siena Biotech Hub to Coordinate European Network. Projects for 2025
The year 2025 will mark the definitive relaunch of the Siena Biotech Hub Foundation. The Italian government aims to posi...
ITTBioMed: the platform to enhance innovation and technology transfer
The weight of biotech in the pharmaceutical sciences is growing from 20% of the drugs produced in 2012 will constitute 8...
TrialSpark technology-first approach to bring new treatments onto the market
Time is crucial, as even a single day saved in the development of a new medication can have a significant impact on pati...